Results 41 to 50 of about 55,766 (252)

Trends in Bacterial Resistance to Fluoroquinolones [PDF]

Clinical Infectious Diseases, 1997
The emergence of resistance to fluoroquinolones in virtually all species of bacteria was recognized soon after the introduction of these compounds for clinical use more than 10 years ago. Various resistance mechanisms, often interdependent, may explain different levels of resistance.
J F, Acar, F W, Goldstein
openaire   +2 more sources

Fluoroquinolone Resistance in Campylobacter

Journal of Food Protection, 2010
Campylobacter is a commensal in poultry, and therefore, poultry and poultry products are major sources of Campylobacter infections in humans. Fluoroquinolones inhibit the growth of Campylobacter and other microorganisms by binding to bacterial DNA gyrase and DNA topoisomerase IV.
James L, Smith, Pina M, Fratamico
openaire   +2 more sources

Molecular surveillance of rising fluoroquinolone resistance in non-invasive S. pneumoniae isolates in Belgium collected in a survey (1995-2014) [PDF]

, 2015
<p>We present the results of a longitudinal surveillance study (1995-2014) on fluoroquinolone resistance (FQ-R) among Belgian non-invasive Streptococcus pneumoniae isolates (n = 5,602). For many years, the switch to respiratory fluoroquinolones for
P.J. Ceyssens, E. Van Bossuyt, J. Verhaegen, P.M. Tulkens, S. Bertrand, The Belgian Streptococcus pneumoniae study group, H.J. Nyssen, R. Vanhoof, F. Fux, S. Damee, W. Mattheus, F. Van Bambeke   +11 more
core   +1 more source

First characterization of fluoroquinolone resistance in Streptococcus suis [PDF]

, 2007
We have identified and sequenced the genes encoding the quinolone-resistance determining region (QRDR) of ParC and GyrA in fluoroquinolone-susceptible and -resistant Streptococcus suis clinical isolates.
Domínguez Rodríguez, Lucas José, San Millán, Álvaro, Escudero García-Calderón, José Antonio, Catalán, Ana, González de la Campa, Adela, González Zorn, Bruno, Rivero, Estefanía, Moreno Romo, Miguel Ángel, Lopez, Gema   +8 more
core   +1 more source

Pseudomonas aeruginosa, Staphylococcus aureus, and Fluoroquinolone Use

Emerging Infectious Diseases, 2005
Few long-term multicenter investigations have evaluated the relationships between aggregate antimicrobial drug use in hospitals and bacterial resistance. We measured fluoroquinolone use from 1999 through 2003 in a network of US hospitals. The percentages
Conan MacDougall, Spencer E. Harpe, J. Patrick Powell, Christopher K. Johnson, Michael B. Edmond, Ron E. Polk   +5 more
doaj   +1 more source

The roles of mutations in gyrA, parC, and ompK35 in fluoroquinolone resistance in Klebsiella pneumoniae [PDF]

, 2008
[[abstract]]In a survey of 541 Klebsiella pneumoniae isolates from 44 hospitals in Taiwan, three distinct populations were identified by the disk diffusion method according to the disribution of zone diameters of ciprofloxacin.
Chen, FJ; Lauderdale, TL; Ho, M; Lo, HJ
core   +1 more source

Antimicrobial resistance among commensal isolates of Escherichia coli and Staphylococcus aureus in the Indonesian population inside and outside hospitals [PDF]

, 2008
The prevalence of antimicrobial resistance among the commensal microflora was examined in the Indonesian population inside and outside hospitals. A total of 3,995 individuals were screened in two major urban centers.
Filius, P. M. G., Verbrugh, H. A., Lestari, ES, Duerink, D. O., Kuntaman, K, Kuntaman , K., Wahjono, H, Severin, Juliette, Severin , J. A, Wahjono, H., Duerink, DO, Hadi, U., Filius, PMG (Margreet), Hadi, U, Lestari , E. S., Verbrugh, Henri   +15 more
core   +1 more source

Characterization of inhibitor-resistant TEM beta-lactamases and mechanisms of fluoroquinolone resistance in Escherichia coli isolates [PDF]

, 2015
The aim of present work was to characterize the inhibitor-resistant TEM (IRT) β-lactamases produced by Escherichia coli in Hospital Clínico San Carlos (Madrid, Spain). Mechanisms of fluoroquinolone resistance among IRT-producing strains were also studied.
López Díaz, María Carmen, Rodríguez-Avial Infante, Iciar, Ríos Dueñas, Esther, Pena, Irene, Picazo De La Garza, Juan José   +4 more
core   +1 more source

Fluoroquinolone Resistance in Neisseria gonorrhoeae [PDF]

Emerging Infectious Diseases, 1997
Fluoroquinolones and broad-spectrum cephalosporins are the most effective antimicrobial agents for the treatment of gonorrhea. However, clinically significant resistance to fluoroquinolones has emerged in Neisseria gonorrhoeae. Fluoroquinolone-resistant strains account for approximately 10% of all gonococcal strains in Hong Kong and the Republic of the
Joan S. Knapp, Kimberley K. Fox, David L. Trees, William L. Whittington   +3 more
openaire   +3 more sources

Fluoroquinolone resistance in Escherichia coli isolates after exposure to non-fluoroquinolone antibiotics: a retrospective case-control study [PDF]

, 2020
: Objectives: To investigate whether prior exposure to non-fluoroquinolone antibiotics increases the risk of fluoroquinolone resistance in Escherichia coli.
Catry, Boudewijn, R. Bruyndonckx, Pinedo, Linda E. Chaname, S. Abrams, Abrams, Steven, B. Catry, K. Latour, S. Coenen, L.E. Chaname Pinedo, Coenen, Samuel, H. Goossens, Goossens, Herman, Bruyndonckx, Robin, Latour, Katrien   +13 more
core   +1 more source